High fluoroquinolone resistance proportions among multidrug-resistant tuberculosis driven by dominant L2 Mycobacterium tuberculosis clones in the Mumbai Metropolitan Region

High fluoroquinolone resistance proportions among multidrug-resistant tuberculosis driven by dominant L2 Mycobacterium tuberculosis clones in the Mumbai Metropolitan Region

<p><strong>Background:</strong> Multidrug-resistant (MDR) <em>Mycobacterium tuberculosis complex</em> (MTBC) strains are a serious health problem in India, also contributing to one-fourth of the global MDR tuberculosis (TB) burden. About 36% o...

Full description

Bibliographic Details
Main Authors:	Dreyer, V, Mandal, A, Dev, P, Merker, M, Barilar, I, Utpatel, C, Nilgiriwala, K, Rodrigues, C, Crook, DW, CRyPTIC Consortium, Rasigade, J-P, Wirth, T, Mistry, N, Niemann, S
Other Authors:	Fowler, PW
Format:	Journal article
Language:	English
Published:	BioMed Central 2022

Similar Items

High fluoroquinolone resistance proportions among multidrug-resistant tuberculosis driven by dominant L2 Mycobacterium tuberculosis clones in the Mumbai Metropolitan Region
by: Viola Dreyer, et al.
Published: (2022-08-01)

Quantitative measurement of antibiotic resistance in Mycobacterium tuberculosis reveals genetic determinants of resistance and susceptibility in a target gene approach
by: The CRyPTIC Consortium
Published: (2024-01-01)

Genome-wide association studies of global Mycobacterium tuberculosis resistance to 13 antimicrobials in 10,228 genomes identify new resistance mechanisms.
by: The CRyPTIC Consortium
Published: (2022-08-01)

A data compendium associating the genomes of 12,289 Mycobacterium tuberculosis isolates with quantitative resistance phenotypes to 13 antibiotics.
by: The CRyPTIC Consortium
Published: (2022-08-01)

Quantitative drug susceptibility testing for Mycobacterium tuberculosis using unassembled sequencing data and machine learning
by: The CRyPTIC consortium
Published: (2024)

Quantitative drug susceptibility testing for Mycobacterium tuberculosis using unassembled sequencing data and machine learning.
by: CRyPTIC consortium
Published: (2024-08-01)

Multi-label random forest model for tuberculosis drug resistance classification and mutation ranking
by: Kouchaki, S, et al.
Published: (2020)

Bedaquiline and clofazimine resistance in Mycobacterium tuberculosis: an in-vitro and in-silico data analysis
by: Sonnenkalb, L, et al.
Published: (2023)

Whole genome sequencing for M/XDR tuberculosis surveillance and for resistance testing
by: Walker, T, et al.
Published: (2016)

Fluoroquinolone resistance in multidrug-resistant tuberculosis patients
by: Hyun-Woo Lee, et al.
Published: (2019-03-01)

Predicting fluoroquinolone resistance in Mycobacterium tuberculosis
by: Brankin, AE
Published: (2023)

Application of machine learning techniques to tuberculosis drug resistance analysis
by: Kouchaki, S, et al.
Published: (2018)

Molecular determinants of multidrug-resistant tuberculosis in Sierra Leone
by: Harriet N. A. Blankson, et al.
Published: (2024-03-01)

EVOLUTION AND TRANSMISSION OF MYCOBACTERIUM TUBERCULOSIS RESISTANCE TO FLUOROQUINOLONES
by: T. Luo
Published: (2018-12-01)

Multi-Label Random Forest Model for Tuberculosis Drug Resistance Classification and Mutation Ranking
by: Samaneh Kouchaki, et al.
Published: (2020-04-01)

Children and Multidrug-Resistant Tuberculosis in Mumbai (Bombay), India
by: Sunil Karande, et al.
Published: (2002-11-01)

Limited Nosocomial Transmission of Drug-Resistant Tuberculosis, Moldova
by: Ecaterina Noroc, et al.
Published: (2023-05-01)

Transmission Dynamics of a Mycobacterium tuberculosis Complex Outbreak in an Indigenous Population in the Colombian Amazon Region
by: Francy J. Pérez-Llanos, et al.
Published: (2023-06-01)

DeepAMR for predicting co-occurrent resistance of Mycobacterium tuberculosis
by: Yang, Y, et al.
Published: (2019)

Protocol for a case–control study of vitamin D status, adult multidrug-resistant tuberculosis disease and tuberculosis infection in Mumbai, India
by: Nerges Mistry, et al.
Published: (2020-11-01)

Compensatory evolution drives multidrug-resistant tuberculosis in Central Asia
by: Matthias Merker, et al.
Published: (2018-10-01)

Genome-wide association studies of global Mycobacterium tuberculosis resistance to 13 antimicrobials in 10,228 genomes identify new resistance mechanisms
by: Earle, SG, et al.
Published: (2022)

Fluoroquinolone-Resistant Mycobacterium tuberculosis, Pakistan, 2005–2009
by: Kauser Jabeen, et al.
Published: (2011-03-01)

Resistance patterns, prevalence, and predictors of fluoroquinolones resistance in multidrug resistant tuberculosis patients
by: Nafees Ahmad, et al.
Published: (2016-01-01)

Fluoroquinolone Resistance in Drug-Resistant Tuberculosis, Kharkiv, Ukraine, 2019–2023
by: Olha Konstantynovska, et al.
Published: (2025-03-01)

Treatment Outcomes of Fluoroquinolone-Resistant Multidrug-Resistant Tuberculosis: An Implication for Delamanid
by: Oki Nugraha Putra, et al.
Published: (2024-04-01)

An end-to-end heterogeneous graph attention network for Mycobacterium tuberculosis drug-resistance prediction
by: Yang, Y, et al.
Published: (2021)

Extrapulmonary drug-resistant tuberculosis at a drug-resistant tuberculosis center, Mumbai: Our experience – Hope in the midst of despair!
by: Unnati Desai, et al.
Published: (2019-01-01)

Real-Time PCR for the Detection of Fluoroquinolone Resistance in Mycobacterium Tuberculosis
by: An, D, et al.
Published: (2008)

The Aftermath of Widal Positivity on the Diagnosis of Tuberculosis and Fluoroquinolone Resistance in India
by: Sumit Bharti, et al.
Published: (2023-04-01)

Genetic surveillance and outcomes of pyrazinamide and fluoroquinolones-resistant tuberculosis in Taiwan
by: Hsin-Ting Huang, et al.
Published: (2023-12-01)

Fluoroquinolone-resistant tuberculosis: implications in settings with weak healthcare systems
by: Kauser Jabeen, et al.
Published: (2015-03-01)

Fluoroquinolone resistant tuberculosis: A case report and literature review
by: Ajaypal Gill, et al.
Published: (2019-01-01)

Evaluation of genetic correlation with fluoroquinolones resistance in rifampicin-resistant Mycobacterium tuberculosis isolates
by: Chong Teng, et al.
Published: (2024-06-01)

IDENTIFICATION OF MUTATIONS OF RESISTANCE TO FLUOROQUINOLONES, AMINOGLYCOSIDES AND ETHAMBUTOL IN RIFAMPICIN-RESISTANT MYCOBACTERIUM TUBERCULOSIS
by: I. V. Bakshtanovskaya, et al.
Published: (2018-12-01)

Pathogen-based precision medicine for drug-resistant tuberculosis
by: Groschel, M, et al.
Published: (2018)

Estimating fitness by competition assays between drug susceptible and resistant Mycobacterium tuberculosis of predominant lineages in Mumbai, India.
by: Purva Bhatter, et al.
Published: (2012-01-01)

Tuberculosis Variant with Rifampin Resistance Undetectable by Xpert MTB/RIF, Botswana
by: Chawangwa Modongo, et al.
Published: (2023-11-01)

Longitudinal Outbreak of Multidrug-Resistant Tuberculosis in a Hospital Setting, Serbia
by: Irena Arandjelović, et al.
Published: (2019-03-01)

Transcontinental spread and evolution of Mycobacterium tuberculosis W148 European/Russian clade toward extensively drug resistant tuberculosis
by: Matthias Merker, et al.
Published: (2022-08-01)